AYTU
Price
$2.29
Change
-$0.03 (-1.29%)
Updated
Oct 17 closing price
Capitalization
22.7M
Intraday Buy/Sell Signals
DBCCF
Price
$0.10
Change
+$0.01 (+11.11%)
Updated
Oct 17 closing price
Capitalization
53.39M
Intraday Buy/Sell Signals
Interact to see
Advertisement

AYTU vs DBCCF

Header iconAYTU vs DBCCF Comparison
Open Charts AYTU vs DBCCFBanner chart's image
Aytu BioPharma
Price$2.29
Change-$0.03 (-1.29%)
Volume$98.99K
Capitalization22.7M
Decibel Cannabis
Price$0.10
Change+$0.01 (+11.11%)
Volume$7.04K
Capitalization53.39M
AYTU vs DBCCF Comparison Chart in %
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DBCCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYTU vs. DBCCF commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Hold and DBCCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (AYTU: $2.29 vs. DBCCF: $0.10)
Brand notoriety: AYTU and DBCCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 47% vs. DBCCF: 6%
Market capitalization -- AYTU: $22.7M vs. DBCCF: $53.39M
AYTU [@Pharmaceuticals: Generic] is valued at $22.7M. DBCCF’s [@Pharmaceuticals: Generic] market capitalization is $53.39M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whileDBCCF’s FA Score has 1 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • DBCCF’s FA Score: 1 green, 4 red.
According to our system of comparison, DBCCF is a better buy in the long-term than AYTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 8 TA indicator(s) are bullish while DBCCF’s TA Score has 3 bullish TA indicator(s).

  • AYTU’s TA Score: 8 bullish, 2 bearish.
  • DBCCF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AYTU is a better buy in the short-term than DBCCF.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -2.97% price change this week, while DBCCF (@Pharmaceuticals: Generic) price change was -4.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBCCF($53.4M) has a higher market cap than AYTU($22.7M). DBCCF YTD gains are higher at: 99.044 vs. AYTU (34.706). DBCCF has higher annual earnings (EBITDA): 21.7M vs. AYTU (10.6M). AYTU has more cash in the bank: 18.2M vs. DBCCF (5.35M). AYTU has less debt than DBCCF: AYTU (21.4M) vs DBCCF (45.9M). DBCCF has higher revenues than AYTU: DBCCF (101M) vs AYTU (81.7M).
AYTUDBCCFAYTU / DBCCF
Capitalization22.7M53.4M43%
EBITDA10.6M21.7M49%
Gain YTD34.70699.04435%
P/E RatioN/A3.36-
Revenue81.7M101M81%
Total Cash18.2M5.35M340%
Total Debt21.4M45.9M47%
FUNDAMENTALS RATINGS
AYTU vs DBCCF: Fundamental Ratings
AYTU
DBCCF
OUTLOOK RATING
1..100
8572
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
8540
PRICE GROWTH RATING
1..100
4238
P/E GROWTH RATING
1..100
6315
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (45) in the Other Consumer Services industry is in the same range as DBCCF (47) in the null industry. This means that AYTU’s stock grew similarly to DBCCF’s over the last 12 months.

DBCCF's Profit vs Risk Rating (86) in the null industry is in the same range as AYTU (100) in the Other Consumer Services industry. This means that DBCCF’s stock grew similarly to AYTU’s over the last 12 months.

DBCCF's SMR Rating (40) in the null industry is somewhat better than the same rating for AYTU (85) in the Other Consumer Services industry. This means that DBCCF’s stock grew somewhat faster than AYTU’s over the last 12 months.

DBCCF's Price Growth Rating (38) in the null industry is in the same range as AYTU (42) in the Other Consumer Services industry. This means that DBCCF’s stock grew similarly to AYTU’s over the last 12 months.

DBCCF's P/E Growth Rating (15) in the null industry is somewhat better than the same rating for AYTU (63) in the Other Consumer Services industry. This means that DBCCF’s stock grew somewhat faster than AYTU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUDBCCF
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DBCCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PJT177.162.43
+1.39%
PJT Partners
LCNB14.610.08
+0.55%
LCNB Corp
VALE11.10-0.01
-0.09%
Vale SA
LIQT2.29-0.02
-0.87%
LiqTech International
SSYS10.92-0.56
-4.88%
Stratasys Ltd

DBCCF and

Correlation & Price change

A.I.dvisor tells us that DBCCF and AYTU have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBCCF and AYTU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBCCF
1D Price
Change %
DBCCF100%
+3.05%
AYTU - DBCCF
21%
Poorly correlated
-1.29%
ESALF - DBCCF
15%
Poorly correlated
N/A
CXXIF - DBCCF
2%
Poorly correlated
-2.03%
CRLBF - DBCCF
2%
Poorly correlated
-8.34%
ELTP - DBCCF
-1%
Poorly correlated
+2.53%
More